ASHLEY SWAGERTY: Open Payments
NPI 1932731775 · OWOSSO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,089 in 411 payments from 19 companies in 2025. Trend: 2023 $3,340 · 2024 $4,563 · 2025 $6,089
Food & beverage: $6,089
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 69 | $989 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 43 | $642 |
| Axsome Therapeutics, Inc. | 29 | $609 |
| ABBVIE INC. | 44 | $589 |
| Vanda Pharmaceuticals Inc. | 31 | $468 |
| Teva Pharmaceuticals USA, Inc. | 39 | $458 |
| Alkermes, Inc. | 26 | $453 |
| Janssen Pharmaceuticals, Inc | 18 | $268 |
| Supernus Pharmaceuticals, Inc. | 20 | $232 |
| E.R. Squibb & Sons, L.L.C. | 18 | $231 |
Products named: REXULTI, CAPLYTA, VRAYLAR, Auvelity, FANAPT, ARISTADA, ABILIFY MAINTENA, AUSTEDO XR.
Industry payments across MI — which companies pay providers there.
